Literature DB >> 1438305

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.

T Taga1, M Narazaki, K Yasukawa, T Saito, D Miki, M Hamaguchi, S Davis, M Shoyab, G D Yancopoulos, T Kishimoto.   

Abstract

Functional pleiotropy and redundancy are characteristic features of cytokines. To understand the signaling mechanisms of such cytokines, we have proposed a two-chain interleukin (IL) 6 receptor model: IL-6 triggers the association of a ligand-binding chain (IL-6 receptor) and a nonbinding signal transducer (gp130) to form a high-affinity receptor complex, resulting in transmission of the signal by the cytoplasmic portion of gp130. This model would explain the functional redundancy of cytokines if we were to assume that gp130 interacts with several different receptor chains. Here we present data indicating that gp130 functions as a common signal transducer for IL-6, oncostatin M, leukemia inhibitory factor, and ciliary neurotrophic factor. We show that anti-gp130 monoclonal antibodies completely block the biological responses induced by all of these factors. Since leukemia inhibitory factor functions as a cholinergic differentiation factor in nerve cells, as does ciliary neurotrophic factor, these results suggest that gp130 may also play a role in the nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438305      PMCID: PMC50470          DOI: 10.1073/pnas.89.22.10998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Molecular cloning and expression of an IL-6 signal transducer, gp130.

Authors:  M Hibi; M Murakami; M Saito; T Hirano; T Taga; T Kishimoto
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

2.  High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor.

Authors:  B L Hempstead; D Martin-Zanca; D R Kaplan; L F Parada; M V Chao
Journal:  Nature       Date:  1991-04-25       Impact factor: 49.962

3.  Purification and characterization of soluble human IL-6 receptor expressed in CHO cells.

Authors:  K Yasukawa; T Saito; T Fukunaga; Y Sekimori; Y Koishihara; H Fukui; Y Ohsugi; T Matsuda; H Yawata; T Hirano
Journal:  J Biochem       Date:  1990-10       Impact factor: 3.387

4.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor.

Authors:  H Baumann; G G Wong
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor.

Authors:  S P Squinto; T N Stitt; T H Aldrich; S Davis; S M Bianco; C Radziejewski; D J Glass; P Masiakowski; M E Furth; D M Valenzuela
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

8.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.

Authors:  K Yasukawa; K Futatsugi; T Saito; H Yawata; M Narazaki; H Suzuki; T Taga; T Kishimoto
Journal:  Immunol Lett       Date:  1992-02       Impact factor: 3.685

10.  Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.

Authors:  D P Gearing; C J Thut; T VandeBos; S D Gimpel; P B Delaney; J King; V Price; D Cosman; M P Beckmann
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  42 in total

1.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

2.  A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.

Authors:  K Mitsuyama; N Tomiyasu; A Suzuki; K Takaki; H Takedatsu; J Masuda; H Yamasaki; S Matsumoto; O Tsuruta; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium.

Authors:  J Dechanet; P Merville; I Durand; J Banchereau; P Miossec
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

4.  Investigating hypothetical products from noncoding frames (HyPNoFs).

Authors:  A Facchiano
Journal:  J Mol Evol       Date:  1995-06       Impact factor: 2.395

Review 5.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

Review 6.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

7.  Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.

Authors:  D P Gearing; S F Ziegler; M R Comeau; D Friend; B Thoma; D Cosman; L Park; B Mosley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Role of the C-terminus in the activity, conformation, and stability of interleukin-6.

Authors:  L D Ward; A Hammacher; J G Zhang; J Weinstock; K Yasukawa; C J Morton; R S Norton; R J Simpson
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

Review 9.  IL-6 cytokine family and signal transduction: a model of the cytokine system.

Authors:  M Hibi; K Nakajima; T Hirano
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

10.  Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells.

Authors:  Valerie A Morris; Almira S Punjabi; Michael Lagunoff
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.